Spots Global Cancer Trial Database for digestive system diseases
Every month we try and update this database with for digestive system diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | NCT00808743 | Familial Adenom... Duodenal Neopla... Duodenal Polyps | Celecoxib Ursodeoxycholic... Placebo | 18 Years - 70 Years | Radboud University Medical Center | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | NCT02993731 | Carcinoma, Panc... | Napabucasin Nab-paclitaxel Gemcitabine | 18 Years - | Sumitomo Pharma America, Inc. | |
| Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | NCT01819766 | Inflammatory Bo... Primary Scleros... Colorectal Neop... Colorectal Canc... | 18 Years - 84 Years | Exact Sciences Corporation | ||
| Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection | NCT04457297 | Colorectal Neop... Trifluridine an... Circulating Tum... | trifluridine an... Placebo | 20 Years - | National Cancer Center Hospital East | |
| Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies | NCT01260168 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 40 Years - 90 Years | Exact Sciences Corporation | ||
| Research on the Application and Mechanism of New Biological Probes in Biomedicine | NCT04977739 | Tumors Cardiovascular ... Respiratory Sys... Digestive Syste... Endocrine Syste... Metabolic Disea... Immune System D... Urinary System ... Nervous System ... Blood Diseases Infectious Dise... | No intervention | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Ovarian Neoplas... Ovarian Disease... Adnexal Disease... Pancreatic Neop... Digestive Syste... Digestive Syste... Pancreatic Dise... | 89Zr-MMOT0530A | 18 Years - | University Medical Center Groningen | |
| Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer | NCT01397747 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 50 Years - 84 Years | Exact Sciences Corporation | ||
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. | NCT02241499 | Adenocarcinoma ... | Radiation thera... Oxaliplatin and... | 18 Years - | Lund University Hospital | |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment | NCT00210249 | Lymphoma Digestive Syste... Ovarian Disease... Pulmonary Disea... Prostatic Disea... Bladder Disease | 70 Years - | Institut Bergonié | ||
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial | NCT01995942 | Adenocarcinoma Rectal Diseases Colorectal Neop... Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial. | NCT02246725 | Tumor in Upper ... | Contact with pa... | 18 Years - | Lund University Hospital | |
| Research on the Application and Mechanism of New Biological Probes in Biomedicine | NCT04977739 | Tumors Cardiovascular ... Respiratory Sys... Digestive Syste... Endocrine Syste... Metabolic Disea... Immune System D... Urinary System ... Nervous System ... Blood Diseases Infectious Dise... | No intervention | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer | NCT01397305 | Rectal Cancer | [6R] 5,10-methy... Pemetrexed | 18 Years - | Isofol Medical AB | |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | NCT01009593 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... Liver Diseases Neoplasms by Hi... Digestive Syste... Carcinoma Liver Neoplasms Neoplasms Neoplasms by Si... Digestive Syste... Adenocarcinoma Neoplasms, Glan... | ABT-869 Sorafenib | 18 Years - | Abbott | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | NCT01088815 | Metastatic Panc... | Gemcitabine, na... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | NCT02112656 | Hepatocellular ... | ThermoDox Dummy infusion | 18 Years - | Imunon | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Research on the Application and Mechanism of New Biological Probes in Biomedicine | NCT04977739 | Tumors Cardiovascular ... Respiratory Sys... Digestive Syste... Endocrine Syste... Metabolic Disea... Immune System D... Urinary System ... Nervous System ... Blood Diseases Infectious Dise... | No intervention | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| Microbiome Test for the Detection of Colorectal Polyps and Cancer | NCT02141945 | Colorectal Neop... Colorectal Canc... | 45 Years - 80 Years | Metabiomics Corp | ||
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Low Rectal Cancer Study (MERCURY II) | NCT02005965 | Adenocarcinoma Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... Rectal Diseases | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | NCT00867113 | Gastrointestina... | imatinib mesyla... | 18 Years - | Novartis | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers | NCT02503631 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Sample Co... | 40 Years - 90 Years | Exact Sciences Corporation | |
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | NCT00808743 | Familial Adenom... Duodenal Neopla... Duodenal Polyps | Celecoxib Ursodeoxycholic... Placebo | 18 Years - 70 Years | Radboud University Medical Center | |
| Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms | NCT01378507 | Digestive Syste... | endoscopic subm... | 18 Years - 90 Years | Chinese PLA General Hospital | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | NCT01009593 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... Liver Diseases Neoplasms by Hi... Digestive Syste... Carcinoma Liver Neoplasms Neoplasms Neoplasms by Si... Digestive Syste... Adenocarcinoma Neoplasms, Glan... | ABT-869 Sorafenib | 18 Years - | Abbott | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | NCT04080843 | Colorectal Canc... RAS and BRAF Wi... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Rectal Diseases | Anlotinib Hydro... Capecitabine Oxaliplatin | 18 Years - 75 Years | Zhejiang University | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| Effect of an Advanced Notification Letter on Screening Colonoscopy Participation | NCT02188927 | Colorectal Canc... Adenoma Rectal Cancer | Implementation ... No included ANL | 55 Years - 64 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors | NCT01177007 | Liver Neoplasms | TheraSphere, Yt... | 18 Years - | Yale University | |
| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | NCT05252078 | Esophageal Squa... Esophageal Neop... Esophageal Dise... Gastrointestina... Gastrointestina... Digestive Syste... Digestive Syste... Neoplasms by Si... Neoplasms by Hi... Neoplasms, Squa... Carcinoma, Squa... | Anlotinib hydro... TQB2450 | 18 Years - | Jiangxi Provincial Cancer Hospital | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer | NCT00838578 | Colorectal Canc... | KRN330 Irinotecan | 18 Years - | Kyowa Kirin Co., Ltd. | |
| TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. | NCT05233098 | Hepatocellular ... | Technetium-99m ... | 21 Years - | Boston Scientific Corporation | |
| TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. | NCT05233098 | Hepatocellular ... | Technetium-99m ... | 21 Years - | Boston Scientific Corporation | |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | NCT05494060 | Carcinoma Gastrointestina... Stomach Cancer Gastroesophagea... Digestive Syste... Gastric Cancer Gastrointestina... | Anlotinib hydro... Penpulimab Inje... XELOX | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment | NCT00210249 | Lymphoma Digestive Syste... Ovarian Disease... Pulmonary Disea... Prostatic Disea... Bladder Disease | 70 Years - | Institut Bergonié | ||
| Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) | NCT03488446 | Digestive Syste... Gastrointestina... Digestive Syste... Gastrointestina... Stomach Neoplas... | 18 Years - | Nanfang Hospital, Southern Medical University | ||
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | NCT01550510 | Stage IV Colore... | Ascorbic Acid Irinotecan | 18 Years - | Thomas Jefferson University | |
| A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | NCT04607421 | Neoplasms | Encorafenib Cetuximab Oxaliplatin Irinotecan Leucovorin 5-FU Capecitabine Bevacizumab | 16 Years - | Pfizer | |
| Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer | NCT01247246 | Oral Mucositis | SCV-07 Placebo | 18 Years - | SciClone Pharmaceuticals | |
| The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin | NCT01549418 | Gastrointestina... | Aspirin (ASA) Placebo | 40 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| ASPIRIN Trial Belgium | NCT03464305 | Colon Cancer | acetylsalicylic... Placebo | 45 Years - | University Hospital, Antwerp | |
| Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma | NCT03077685 | Locally Advance... | NanoPac® | 18 Years - | NanOlogy, LLC | |
| Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | NCT06365866 | Esophageal Neop... Head and Neck N... Gastrointestina... Digestive Syste... Digestive Syste... Esophageal Dise... Neoplasms by Si... Gastrointestina... Neoplasms | "BRAXX" Esophag... Add-on of intra... | 20 Years - 85 Years | Taipei Veterans General Hospital, Taiwan | |
| Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | NCT01819766 | Inflammatory Bo... Primary Scleros... Colorectal Neop... Colorectal Canc... | 18 Years - 84 Years | Exact Sciences Corporation | ||
| Effect of an Advanced Notification Letter on Screening Colonoscopy Participation | NCT02188927 | Colorectal Canc... Adenoma Rectal Cancer | Implementation ... No included ANL | 55 Years - 64 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Low Rectal Cancer Study (MERCURY II) | NCT02005965 | Adenocarcinoma Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... Rectal Diseases | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers | NCT03122548 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | CRS-207 Pembrolizumab | 18 Years - | Aduro Biotech, Inc. | |
| Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer | NCT02292173 | Hepatocellular ... Liver Cancer | Trametinib Sorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection | NCT04457297 | Colorectal Neop... Trifluridine an... Circulating Tum... | trifluridine an... Placebo | 20 Years - | National Cancer Center Hospital East | |
| Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing | NCT01600209 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 50 Years - 84 Years | Exact Sciences Corporation | ||
| TheraSphere With Durvalumab and Tremelimumab for HCC | NCT05063565 | Hepatocellular ... | TheraSphere Y-9... Durvalumab (Imf... Tremelimumab im... | 18 Years - | Boston Scientific Corporation | |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | NCT04080843 | Colorectal Canc... RAS and BRAF Wi... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Rectal Diseases | Anlotinib Hydro... Capecitabine Oxaliplatin | 18 Years - 75 Years | Zhejiang University | |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| Evolution® Biliary Stent System Clinical Study | NCT01962168 | Biliary Tract N... Neoplasms Gastrointestina... Digestive Syste... Biliary Tract Stents | Evolution® Bili... | 18 Years - | Cook Group Incorporated | |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | NCT01964430 | Pancreatic Neop... Digestive Syste... Neoplasms by Si... Neoplasms Endocrine Gland... Pancreatic Dise... Digestive Syste... Endocrine Syste... Gemcitabine Antimetabolites... | nab-Paclitaxel Gemcitabine | 18 Years - | Celgene | |
| A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer | NCT02753127 | Colorectal Canc... | Napabucasin Fluorouracil Leucovorin Irinotecan Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) | NCT02503696 | Inflammatory Bo... Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Collectio... | 18 Years - 84 Years | Exact Sciences Corporation | |
| Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers | NCT03122548 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | CRS-207 Pembrolizumab | 18 Years - | Aduro Biotech, Inc. | |
| Point of Care 3D Ultrasound for Various Applications: A Pilot Study | NCT02831556 | Appendicitis Evidence of Cho... Gallstones Pregnancy, Ecto... Aortic Aneurysm Kidney Stones Intrauterine Pr... Diverticulitis Abdominal Injur... Tumors Pancreatitis Digestive Syste... Gastrointestina... Intraabdominal ... Intestinal Dise... Pregnancy Vascular Diseas... Uterine Fibroid... Ovarian Cysts Uterine Abnomin... Bladder Abnomin... Testicular Abno... Polyps | - | Duke University | ||
| Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) | NCT02503696 | Inflammatory Bo... Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Collectio... | 18 Years - 84 Years | Exact Sciences Corporation | |
| Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. | NCT02241499 | Adenocarcinoma ... | Radiation thera... Oxaliplatin and... | 18 Years - | Lund University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
